{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T11:45:41Z","timestamp":1773661541262,"version":"3.50.1"},"reference-count":13,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[1982,3,1]],"date-time":"1982-03-01T00:00:00Z","timestamp":383788800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1982,3,1]],"date-time":"1982-03-01T00:00:00Z","timestamp":383788800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[1982,3]]},"DOI":"10.1378\/chest.81.3.308","type":"journal-article","created":{"date-parts":[[2007,11,7]],"date-time":"2007-11-07T13:25:26Z","timestamp":1194441926000},"page":"308-311","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Clinical Use of Oral Verapamil in Chronic and Paroxysmal Atrial Fibrillation"],"prefix":"10.1016","volume":"81","author":[{"given":"Eric H.","family":"Stern","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Pitchon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard D.","family":"King","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Guerrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard R.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isaac","family":"Wiener","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1378\/chest.81.3.308_bib1","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/0002-9149(75)90051-X","article-title":"Inefficacy of \u201ctherapeutic\u201d serum levels of digoxin in controlling the ventricular rate in atrial fibrillation.","volume":"35","author":"Goldman","year":"1975","journal-title":"Am J Cardiol"},{"issue":"Suppl 2","key":"10.1378\/chest.81.3.308_bib2","first-page":"114","article-title":"Digoxin: how effective for rate control in ambulatory patients with atrial fibrillation (abstract).","volume":"46","author":"Belic","year":"1972","journal-title":"Circulation"},{"key":"10.1378\/chest.81.3.308_bib3","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0033-0620(80)90011-0","article-title":"New perspectives in the pharmacologic therapy of cardiac arrhythmias.","volume":"22","author":"Singh","year":"1980","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1378\/chest.81.3.308_bib4","doi-asserted-by":"crossref","first-page":"875","DOI":"10.7326\/0003-4819-93-6-875","article-title":"Calcium channel blocking agents in the treatment of cardiovascular disorders. Part I: Basic and clinical electrophysiologic effects.","volume":"93","author":"Antman","year":"1980","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.81.3.308_bib5","doi-asserted-by":"crossref","first-page":"886","DOI":"10.7326\/0003-4819-93-6-886","article-title":"Calcium channel blocking agents in the treatment of cardiovascular disorders. Part II: Hemodynamic effects and clinical applications.","volume":"93","author":"Stone","year":"1980","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.81.3.308_bib6","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1136\/bmj.1.5801.660","article-title":"Immediate effects of intravenous verapamil in cardiac arrhythmias.","volume":"1","author":"Schamroth","year":"1972","journal-title":"Br Med J"},{"key":"10.1378\/chest.81.3.308_bib7","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1001\/archinte.1979.03630440017009","article-title":"The beneficial effects of verapamil in chronic atrial fibrillation.","volume":"139","author":"Klein","year":"1979","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.81.3.308_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-94-1-1","article-title":"Verapamil for control of ventricular rate in paroxysmal supraventricular tachycardia and atrial fibrillation or flutter.","volume":"94","author":"Waxman","year":"1981","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.81.3.308_bib9","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1161\/01.CIR.62.5.996","article-title":"Effects of intravenous and chronic oral verapamil administration in patients with supraventricular tachyarrhythmias.","volume":"62","author":"Rinkenberger","year":"1980","journal-title":"Circulation"},{"key":"10.1378\/chest.81.3.308_bib10","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1161\/01.RES.35.3.413","article-title":"Effect of verapamil on the sinoatrial and atrioventricular nodes of the rabbit and the mechanism by which it arrests re-entrant atrioventricular nodal tachycardia.","volume":"35","author":"Wit","year":"1974","journal-title":"Circ Res"},{"issue":"4, Part II","key":"10.1378\/chest.81.3.308_bib11","first-page":"305","article-title":"Effect of verapamil on blood level and renal clearance of digoxin (abstract).","volume":"62","author":"Lang","year":"1980","journal-title":"Circulation"},{"key":"10.1378\/chest.81.3.308_bib12","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/0033-0620(69)90033-4","article-title":"The use of beta-adrenergic blocking drugs in dysrhythmias.","volume":"12","author":"Gibson","year":"1969","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1378\/chest.81.3.308_bib13","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/0002-9149(66)90071-3","article-title":"Unwanted effects of propranolol.","volume":"18","author":"Stephen","year":"1966","journal-title":"Am J Cardiol"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215338277?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215338277?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T06:46:32Z","timestamp":1757918792000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369215338277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1982,3]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1982,3]]}},"alternative-id":["S0012369215338277"],"URL":"https:\/\/doi.org\/10.1378\/chest.81.3.308","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[1982,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Use of Oral Verapamil in Chronic and Paroxysmal Atrial Fibrillation","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1378\/chest.81.3.308","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1378\/chest.81.3.302","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1982 The American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}